Annual Report 2010 - CDON Group
Annual Report 2010 - CDON Group
Annual Report 2010 - CDON Group
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
72 <strong>CDON</strong> <strong>Group</strong> AB<br />
<strong>Annual</strong> report <strong>2010</strong><br />
<strong>CDON</strong> <strong>Group</strong> AB<br />
<strong>Annual</strong> report <strong>2010</strong><br />
Impairment testing for cash-generating units containing trademarks<br />
The following cash-generating units, which coincide with the <strong>Group</strong>’s reporting segments, recognise significant values for trademarks in<br />
relation to the <strong>Group</strong>’s total recognised value for trademarks:<br />
(SEK thousands) <strong>2010</strong> 2009<br />
Sports & Health 48,896 38,873<br />
Entertainment 5,138 -<br />
Total 54,034 38,873<br />
Impairment testing<br />
Impairment testing for trademarks for cash-generating units in the segment is based on recoverable value (value in use), calculated using<br />
a discounted cash flow model. The model includes terminal value, market growth rate, and working capital requirements. These cash flow<br />
projections calculated over a five year period are based on actual operating results, forecasts and financial projections, historical trends,<br />
general market conditions, industry trends, and other available information.<br />
Cash flow projections are based on a sustainable growth rate that is individually calculated based on the each unit’s outlook. Individual<br />
assumptions are also made on expenses and capital turnover development. The cash flow is discounted for each unit using an appropriate<br />
discount rate, taking into consideration the cost of capital and risk, and with individual consideration taken only in special circumstances.<br />
The cash flow calculated for each segment after the first five years was based on an annual growth rate of 2.5%. The calculated cash flow<br />
has been calculated at present value at a discount rate of 9.3% before tax.<br />
Sensitivity<br />
The impairment testing performed does not indicate any need to take an impairment loss. Impairment testing generally has a margin such<br />
that any adverse changes in individual parameters reasonably possible would not cause the value in use to fall below the book value.<br />
However, the cash flow projections are uncertain and may also be influenced by factors not in control by the company. Even if the<br />
estimated growth rate applied after the forecasted 5-year period had been 1.5% instead of the management estimate of 2.5%, there<br />
would be no need to recognise an impairment loss for trademarks. Even if the estimated discount rate for tax applied for discounted cash<br />
flows had been 10.3% instead of the management estimate of 9.3%, there would be no need to recognise an impairment loss on<br />
trademarks.<br />
Note 10 Property, plant, and equipment<br />
<strong>Group</strong><br />
Equipment <strong>2010</strong> 2009<br />
Opening accumulated cost 5,856 4,082<br />
Investments 3,201 1,662<br />
Investments through business combinations 152 -<br />
Reclassifications - 125<br />
Divestments -23 -<br />
Translation differences - -13<br />
Closing accumulated acquisition value 9,186 5,856<br />
Opening accumulated depreciation -3,903 -2,703<br />
Year's depreciation -1,581 -1,006<br />
Depreciation through acquisition -61 -<br />
Impairment for the year - -106<br />
Reclassifications - -96<br />
Divestments 19 -<br />
Translation differences - 8<br />
Closing accumulated depreciation -5,526 -3,903<br />
Carrying amount 3,660 1,953<br />
Depreciation expenses of SEK 1,581 thousand (1,006) are included in sales & administrative expenses. Impairment expenses of SEK 0<br />
thousand (106) are included in sales & administrative expenses.